InvestorsHub Logo

DewDiligence

01/20/16 8:07 PM

#11925 RE: DewDiligence #11852

More discussion of the thematic RVNC:

#msg-119914098

Please see the Reply chain to that post for related info.

DewDiligence

02/05/16 5:02 PM

#12062 RE: DewDiligence #11852

I’ve been steadily adding to RVNC on the way down. Don’t know where the bottom is, but the stock is now (mis)priced as though the company’s botulinum toxin will never make it to market. (Also see #msg-119914098.)

DewDiligence

03/03/16 9:22 AM

#12226 RE: DewDiligence #11852

On last night’s CC, RNVC disclosed that the full dataset from the phase-2 BELMONT study in glabellar lines will be presented at AAD this weekend, which could lift the stock today.

p.s. RVNC has strong liquidity ($254.1M at 12/31/15): #msg-120921973.

ChikiTiny

03/27/16 7:03 AM

#12358 RE: DewDiligence #11852

Is that really any different from other high end consumer discretionary items... for example diamonds?

DewDiligence

07/23/16 12:52 PM

#12909 RE: DewDiligence #11852

DewDiligence

08/03/16 1:05 PM

#12996 RE: DewDiligence #11852

RVNC:

DewDiligence

09/16/16 10:53 AM

#13299 RE: DewDiligence #11852

RVNC +15%—No news I’m aware of, but I stand by this post from June: #msg-123290722.

DewDiligence

12/23/16 1:56 PM

#13854 RE: DewDiligence #11852

RVNC +63% since US presidential election (eom).

DewDiligence

01/05/17 3:44 PM

#13948 RE: DewDiligence #11852

Cover story of Time—>good for RVNC:



http://time.com/4623409/botox-drug-treating-everything

DewDiligence

01/31/17 5:24 PM

#14118 RE: DewDiligence #11852

RVNC—Global botulinum-toxin market to reach $7.3B in 2025, says market-research firm:

#msg-128312892

I think their forecast is actually a little low.

DewDiligence

05/29/18 5:34 PM

#16715 RE: DewDiligence #11852

Brief musings on RVNC and EOLS: #msg-141148357.

DewDiligence

08/03/18 9:40 PM

#16974 RE: DewDiligence #11852

RVNC’s enterprise value is only $880M (cheap): #msg-142681157.

DewDiligence

11/03/18 4:41 PM

#17495 RE: DewDiligence #11852

Musings on RVNC’s valuation: #msg-144655043.

DewDiligence

01/17/19 7:34 AM

#17865 RE: DewDiligence #11852

Musings on RVNC’s offering and post-offering opportunity: #msg-146164001.

DewDiligence

03/03/19 8:53 PM

#18096 RE: DewDiligence #11852

Musings on RVNC’s (shockingly cheap) valuation: #msg-147254337.

DewDiligence

05/02/19 10:40 AM

#18525 RE: DewDiligence #11852

SY IPOs 14.95M* ADSs @$13.80:

https://www.globenewswire.com/news-release/2019/05/02/1814064/0/en/So-Young-Announces-Pricing-of-Initial-Public-Offering.html

So-Young International Inc. (NASDAQ: SY) is the most popular online destination for discovering, evaluating and reserving medical aesthetic services in China.

Each ADS is equivalent to 0.769 Chinese shares, which is a peculiar ratio (10/13).

No endorsement by me implied.

*Assuming exercise of underwriter’s option.

DewDiligence

05/08/19 7:25 PM

#18632 RE: DewDiligence #11852

RVNC hits new low on ~3-month delay in BLA filing: #msg-148695823.

DewDiligence

06/06/19 6:37 PM

#18895 RE: DewDiligence #11852

RVNC—Notable comment from a competitor: #msg-149253306.

DewDiligence

10/30/19 1:56 PM

#19879 RE: DewDiligence #11852

DewDiligence

08/28/20 4:13 PM

#22779 RE: DewDiligence #11852

RVNC—Having fun with potential brand names for Daxi:

https://twitter.com/DewDiligence/status/1299436172310188034

DewDiligence

10/07/20 1:53 PM

#22924 RE: DewDiligence #11852

(RVNC)—ABBV acquires dermal-filler for undisclosed price: #msg-158759684.

DewDiligence

10/25/20 7:04 PM

#22981 RE: DewDiligence #11852

RVNC is thematic for this board:

https://www.wsj.com/articles/brazilians-turn-to-botox-to-wipe-away-that-quarantine-frown-11603645858

…dermatologists and beauty clinics in major cities such as São Paulo and Rio de Janeiro say they are carrying out around 20% to 100% more treatments a month than they did before the pandemic. It is partly due to pent up demand, they say, after many establishments closed down in March and April. However, they are also seeing an influx of Botox first timers. Many of them are men.

DewDiligence

07/30/21 10:23 AM

#24402 RE: DewDiligence #11852

(RVNC)—Botox printed some great numbers in 2Q21: #msg-165190807.

DewDiligence

10/18/21 8:27 AM

#24740 RE: DewDiligence #11852

RVNC receives FDA CRL due to manufacturing deficiencies; Daxi approval now delayed until late-2022/early-2023:

#msg-166381938 (PR)
#msg-166383002 (the new timeline)
#msg-166382900 (why I’m not selling)
#msg-166386025 (cash burn should lessen)